Boston

Alzheimer’s Association blasts Biogen over price of new drug Aduhelm – Boston, Massachusetts

Boston, Massachusetts 2021-06-12 18:08:08 –

IIn a harsh tone, the Alzheimer’s Association sharply criticized Biogen (BIIB) For the $ 56,000 price tag placed on it Newly approved A move that could involve Alzheimer’s disease treatment, biotechnology companies and their medicines in yet another national controversy.

Patient advocacy groups easy explanation Calling wholesale prices “simply unacceptable” on Saturday, he said that for many, it “provides an insurmountable barrier to access and could further deepen the problem of health inequalities.” The organization thanked the drug for its approval in response to its “expansive unmet needs,” but asked Biogen to change its price.

Sign up for STAT + to unlock this article and enjoy the first 30 days for free!

let’s start



Alzheimer’s Association blasts Biogen over price of new drug Aduhelm Source link Alzheimer’s Association blasts Biogen over price of new drug Aduhelm

Back to top button